Stay updated on ACTT: Remdesivir for Severe COVID-19 Clinical Trial
Sign up to get notified when there's something new on the ACTT: Remdesivir for Severe COVID-19 Clinical Trial page.

Latest updates to the ACTT: Remdesivir for Severe COVID-19 Clinical Trial page
- Check3 days agoChange DetectedA new Revision: v3.7.0 has been added and Revision: v3.6.6 has been removed, indicating an update to the ACTT study's documentation on the page. This update reflects revised protocol details and associated study documentation.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page revision label updated from v3.6.5 to v3.6.6, indicating a new deployment of the study details page. This likely reflects minor fixes or updates to the page rendering or metadata without altering the study information presented to users.SummaryDifference0.0%

- Check38 days agoChange DetectedThe page's revision tag was updated from v3.6.4 to v3.6.5, signaling a minor update to the documentation or UI without substantive changes to the study information.SummaryDifference0.0%

- Check60 days agoChange DetectedRevision label in the Study Documents area was updated from v3.6.3 to v3.6.4, indicating a newer version of the protocol document is now referenced.SummaryDifference0.0%

- Check82 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing the previous v3.6.0. This indicates a patch-level update to the page's revision history without altering the core content of the study details.SummaryDifference0.0%

- Check89 days agoChange Detected- Added a new publication reference (Lin et al.) to the study record. This article discusses evaluating treatment efficacy in hospitalized COVID-19 patients and its applications to Adaptive COVID-19 Treatment Trials, expanding the record's related literature.SummaryDifference0.0%

Stay in the know with updates to ACTT: Remdesivir for Severe COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ACTT: Remdesivir for Severe COVID-19 Clinical Trial page.